Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 3,000 | 8,755 | 3,449 | 7,904 | 3,598 |
| Gross Profit | 3,000 | 8,755 | 3,449 | 7,904 | 3,598 |
| Operating Expenses | 37,740 | 26,965 | 29,425 | 31,371 | 9,777 |
| Operating Income | -34,740 | -18,210 | -25,976 | -23,467 | -6,179 |
| Interest Expense | 231 | 886 | 1,119 | 923 | 667 |
| Other Income | 12 | -7 | 87 | -20 | 37 |
| Pre-tax Income | -34,959 | -19,103 | -27,008 | -24,410 | -6,809 |
| Net Income Continuous | -34,959 | -19,103 | -27,008 | -24,410 | -6,809 |
| Net Income | $-34,959 | $-19,103 | $-27,008 | $-24,410 | $-6,809 |
| EPS Basic Total Ops | -259.40 | -227.40 | -426.00 | -440.00 | -880.00 |
| EPS Basic Continuous Ops | -259.47 | -227.28 | -426.06 | -439.20 | -843.22 |
| EPS Diluted Total Ops | -259.40 | -227.40 | -426.00 | -440.00 | -880.00 |
| EPS Diluted Continuous Ops | -259.47 | -227.28 | -426.06 | -439.20 | -843.22 |
| EPS Diluted Before Non-Recurring Items | -260.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-34,718 | $-18,054 | $-25,779 | $-23,311 | $-6,065 |